{"id":468439,"date":"2018-04-26T12:59:56","date_gmt":"2018-04-26T16:59:56","guid":{"rendered":"https:\/\/www.sciencedaily.com\/releases\/2018\/04\/180426125956.htm"},"modified":"2018-04-26T12:59:56","modified_gmt":"2018-04-26T16:59:56","slug":"biomarkers-and-efficacy-of-vaccine-responses-among-patients-treated-with-new-ms-drug","status":"publish","type":"post","link":"https:\/\/spaceweekly.com\/?p=468439","title":{"rendered":"Biomarkers and efficacy of vaccine responses among patients treated with new MS drug"},"content":{"rendered":"<p>In March 2017, the US Food and Drug Administration approved ocrelizumab as the first treatment for both relapsing (RMS) and progressive forms of multiple sclerosis (MS), a genetic disease that afflicts approximately 400,000 Americans with an estimated 10,000 new cases every year. Neurologists have now looked more deeply into the impact of ocrelizumab in these patients. <\/p>\n","protected":false},"excerpt":{"rendered":"<p>In March 2017, the US Food and Drug Administration approved ocrelizumab as the first treatment for both relapsing (RMS) and progressive forms of multiple sclerosis (MS), a genetic disease that afflicts approximately 400,000 Americans with an estimated &#8230;<\/p>\n","protected":false},"author":61,"featured_media":615444,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-468439","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry"],"_links":{"self":[{"href":"https:\/\/spaceweekly.com\/index.php?rest_route=\/wp\/v2\/posts\/468439","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/spaceweekly.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/spaceweekly.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/spaceweekly.com\/index.php?rest_route=\/wp\/v2\/users\/61"}],"replies":[{"embeddable":true,"href":"https:\/\/spaceweekly.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=468439"}],"version-history":[{"count":1,"href":"https:\/\/spaceweekly.com\/index.php?rest_route=\/wp\/v2\/posts\/468439\/revisions"}],"predecessor-version":[{"id":468440,"href":"https:\/\/spaceweekly.com\/index.php?rest_route=\/wp\/v2\/posts\/468439\/revisions\/468440"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/spaceweekly.com\/index.php?rest_route=\/wp\/v2\/media\/615444"}],"wp:attachment":[{"href":"https:\/\/spaceweekly.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=468439"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/spaceweekly.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=468439"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/spaceweekly.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=468439"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}